Colleen Delaney
Company: Deverra Therapeutics
Job title: Founder & Chief Scientific Officer, Executive Vice President - Research & Development
Seminars:
Panel Discussion: What Criteria Make the Ideal Starting Material for Allogeneic Products? 3:30 pm
View the full event guide for more detailsRead more
day: Manufacturing Track Day One PM
Overcoming Hurdles in Allogeneic Cell Therapy Development Using Pooled Donor Cord Blood CD34+ Cells as the Starting Material 5:30 pm
View the full event guide for more detailsRead more
day: Conference Day One